These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Arachidonic acid, leukotriene B4, and neutrophil activation. Naccache PH; Sha'afi RI Ann N Y Acad Sci; 1983; 414():125-39. PubMed ID: 6322649 [No Abstract] [Full Text] [Related]
10. Methanol is a potent inhibitor of the metabolism of endogenous arachidonic acid by elicited rat peritoneal leukocytes. Dawson M; McGee CM; Smith MD; Brooks PM Prostaglandins; 1990 Apr; 39(4):395-406. PubMed ID: 2160677 [TBL] [Abstract][Full Text] [Related]
11. Comparison of the eosinophil chemotactic factor (ECF) with endogeneous hydroxyeicosatetraenoic acids of leukocytes. König W; Kroegel C; Kunau HW; Borgeat P Int Arch Allergy Appl Immunol; 1981; 66 Suppl 1():168-71. PubMed ID: 6273325 [No Abstract] [Full Text] [Related]
12. Effects of sulfasalazine and a sulfasalazine analogue on the formation of lipoxygenase and cyclooxygenase products. Tornhamre S; Edenius C; Smedegård G; Sjöquist B; Lindgren JA Eur J Pharmacol; 1989 Oct; 169(2-3):225-34. PubMed ID: 2572437 [TBL] [Abstract][Full Text] [Related]
14. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Samuelsson B Science; 1983 May; 220(4597):568-75. PubMed ID: 6301011 [TBL] [Abstract][Full Text] [Related]
15. Ebselen reduces the formation of LTB4 in human and porcine leukocytes by isomerisation to its 5S, 12R-6-trans-isomer. Kuhl P; Borbe HO; Fischer H; Römer A; Safayhi H Prostaglandins; 1986 Jun; 31(6):1029-48. PubMed ID: 3020614 [TBL] [Abstract][Full Text] [Related]
16. In vivo evidence for the chemotactic activity of cyclooxygenase- and lipoxygenase-dependent compounds using a corneal implantation technique. Rochels R; Busse WD Ophthalmic Res; 1984; 16(4):194-7. PubMed ID: 6089067 [TBL] [Abstract][Full Text] [Related]
17. Arachidonic acid monooxygenase and lipoxygenase activities in polymorphonuclear leukocytes. Bednar M; Kraemer R; Abraham NG; Mullane KM Biochem Pharmacol; 1987 May; 36(10):1741-7. PubMed ID: 3036155 [No Abstract] [Full Text] [Related]
18. [Pharmacology of the leukotrienes]. Sirois P; Borgeat P J Pharmacol; 1984; 15 Suppl 1():53-68. PubMed ID: 6328128 [TBL] [Abstract][Full Text] [Related]
19. Is eosinophil chemotactic factor identical with leukotriene B? Czarnetzki BM Int Arch Allergy Appl Immunol; 1982; 67(2):181-3. PubMed ID: 6276308 [TBL] [Abstract][Full Text] [Related]
20. [The potential and significance of pharmacologic effects on leukotrienes and other lipoxygenase derivatives of arachidonic acid]. Mayer M; Opavský J Vnitr Lek; 1987 May; 33(5):502-7. PubMed ID: 3037786 [No Abstract] [Full Text] [Related] [Next] [New Search]